About The Webinar

Foreign-trade zones are an effective tool for manufacturers and importers to avoid, reduce, or defer duties. FTZs also offer unique benefits that can help strengthen global supply chains for biopharma and life sciences companies, which can use them for purposes like labeling and testing products, preparing for a drug launch, and receiving returned product for analysis.

This webinar explores how to determine whether an FTZ is a practical option for your business and how to set one up and operate it. In addition, the following topics will be discussed with real-life examples from the biopharma and life sciences industry.

Contact if you have issues registering. Please note we do not take American Express.

Key Topics

  • reducing, eliminating, and deferring duties in an FTZ
  • general-purpose zones vs. subzones or usage-driven sites
  • permitted activities
  • FTZ benefits
  • privileged foreign, non-privileged foreign, and zone-restricted merchandise
  • status of goods entering an FTZ
  • best compliance practices

Please note we do not accept payment via American Express.



Andrea K. Jeglum


ANDREA K. JEGLUM is an associate for Sandler, Travis & Rosenberg, P.A., located in the Boston area. She concentrates her practice on customs compliance matters including tariff classification, country of origin, valuation, trade agreements, foreign-trade zones, and duty reduction programs. Prior to joining ST&R Ms. Jeglum served for more than 15 years leading global pharmaceutical and biotechnology companies through the complexities of global trade and related regulatory compliance matters.


Scott Taylor

Member & FTZ Practice Leader

SCOTT TAYLOR is a member of Sandler, Travis & Rosenberg, P.A. and leader of our foreign-trade zones practice area, where he represents clients across a variety of industries in the area of international trade, customs, and foreign-trade zone law.



Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.